You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 8, August 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Alert me on articles by topic

Experimental Destruction of Substantia Nigra Initiated by Parkinson Disease Immunoglobulins

Shengdi Chen, MD; Weidong D. Le, MD, PhD; Wenjie J. Xie, MD; Maria E. Alexianu, MD, PhD; Joseph I. Engelhardt, MD, PhD; Laszlo Siklós, PhD; Stanley H. Appel, MD

Arch Neurol. 1998;55:1075-1080.

Background  Increased levels of free radicals and oxidative stress may contribute to the pathogenesis of substantia nigra (SN) injury in Parkinson disease (PD), but the initiating etiologic factors remain undefined in most cases.

Objective  To determine the potential importance of immune mechanisms in triggering or amplifying neuronal injury, we assayed serum samples from patients with PD to determine the ability of IgG to initiate relatively specific SN injury in vivo.

Methods  IgG purified from the serum of 5 patients with PD and 10 disease control (DC) patients was injected into the right side of the SN in adult rats. Coronal sections were cut from the whole brain at the level of the stereotaxic injections, stained for tyrosine hydroxylase and with cresyl violet, and cellular profiles were counted in identical brain regions at the injection and contralateral sides. The ratio of cell profile counts of the corresponding injected and uninjected regions was used as an internal standard.

Results  Four weeks following injection of IgG, a 50% decrease in tyrosine hydroxylase–positive cellular profiles was noted on the injected sides compared with the contralateral sides of the same animals. Similarly, applied DC IgG caused only an 18% decrease. Cresyl violet staining revealed a 35% decrease in neuronal profiles of PD IgG injected into the SN pars compacta compared with the contralateral uninjected side, whereas DC IgG caused a minimal 10% decrease. Even at 4 weeks after the PD IgG injections, perivascular inflammation and significant microglial infiltration were present near injured SN pars compacta neurons. No cytotoxic effects of PD IgG were noted in choline acetyltransferase–positive neurons after stereotaxic injections into the medial septal region. Absorption of PD IgG with mesencephalic membranes and protein A agarose gel beads removed cytotoxicity, while absorption with liver membranes did not change the cytotoxicity.

Conclusions  Our data suggest that PD IgG can initiate a relatively specific inflammatory destruction of SN pars compacta neurons in vivo and demonstrate the potential relevance of immune mechanisms in PD.


From the Department of Neurology, Baylor College of Medicine, Houston, Tex (Drs Chen, Le, Xie, Alexianu, Engelhardt, Siklós, and Appel); the Department of Neurology, Shanghai Second Medical University, Shanghai, China (Dr Chen); the Departments of Neurology and Psychiatry, Albert Szent-Györgyi School of Medicine (Dr Engelhardt), the Institute of Biophysics, Biological Research Center (Dr Siklós), and the Joint Program of the Biological Research Center of the Hungarian Academy of Sciences and Albert Szent-Györgyi Medical University (Drs Engelhardt and Siklós), Szeged, Hungary.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease
Le et al.
J. Neurosci. 2001;21:8447-8455.
ABSTRACT | FULL TEXT  

Increase in Peripheral CD4 Bright+ CD8 Dull+ T Cells in Parkinson Disease
Hisanaga et al.
Arch Neurol 2001;58:1580-1583.
ABSTRACT | FULL TEXT  

Monoclonal antibodies against Epstein-Barr virus cross-react with {alpha}-synuclein in human brain
Woulfe et al.
Neurology 2000;55:1398-1401.
ABSTRACT | FULL TEXT  

Stereotaxic Injection of IgG From Patients With Alzheimer Disease Initiates Injury of Cholinergic Neurons of the Basal Forebrain
Engelhardt et al.
Arch Neurol 2000;57:681-686.
ABSTRACT | FULL TEXT  

Effects of Cerebrospinal Fluid From Patients With Parkinson Disease on Dopaminergic Cells
Le et al.
Arch Neurol 1999;56:194-200.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.